Moderna COVID-19 vaccine shows 94.1 per cent efficacy in trial: Study

The study, published on Wednesday in The New England Journal of Medicine, found that among over 30,000 participants randomised to receive the vaccine or a placebo, 11 in the vaccine group developed symptomatic COVID-19 compared to 185 participants who received the placebo.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2X0dmjU
via IFTTT